Treatment with Insulin Analog X10 and IGF-1 Increases Growth of Colon Cancer Allografts

Open Access

Peer-reviewed

Research Article

Henning Hvid ,

* E-mail: hhvd@novonordisk.com

Affiliation Diabetes Research Unit, Novo Nordisk A/S, Maaloev, Denmark
⨯
Marie-José Blouin,

Affiliation Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada
⨯
Elena Birman,

Affiliation Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada
⨯
Jesper Damgaard,

Affiliation Diabetes Research Unit, Novo Nordisk A/S, Maaloev, Denmark
⨯
Fritz Poulsen,

Affiliation Diabetes Research Unit, Novo Nordisk A/S, Maaloev, Denmark
⨯
Johannes Josef Fels,

Affiliation Diabetes Research Unit, Novo Nordisk A/S, Maaloev, Denmark
⨯
Christian Fledelius,

Affiliation Diabetes Research Unit, Novo Nordisk A/S, Maaloev, Denmark
⨯
Bo Falck Hansen,

Affiliation Diabetes Research Unit, Novo Nordisk A/S, Maaloev, Denmark
⨯
Michael Pollak

Affiliation Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada
⨯

Reader Comments (0)

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Insulin
Is the Subject Area "Insulin" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Blood plasma
Is the Subject Area "Blood plasma" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Colon
Is the Subject Area "Colon" applicable to this article?

Thanks for your feedback.
Blood sugar
Is the Subject Area "Blood sugar" applicable to this article?

Thanks for your feedback.